Table 5 Multivariate survival model analysis based on TIMER online tool
Clinicopathologic variable | Coef | HR (95% CI) | P-value | Sig |
|---|---|---|---|---|
Age | 0.012 | 1.01 (1.00–1.03) | 0.177 | |
Gender Male | − 0.071 | 0.93 (0.58–1.50) | 0.769 | |
Race Black | 1.185 | 3.27 (1.18–9.04) | 0.022 | * |
Race White | − 0.032 | 0.97 (0.58–1.61) | 0.902 | |
Stage II | 0.174 | 1.19 (0.70–2.02) | 0.522 | |
Stage III | 0.711 | 2.04 (1.24–3.33) | 0.005 | ** |
Stage IV | 1.434 | 4.19 (1.20–14.60) | 0.024 | * |
Purity | 0.561 | 1.75 (0.55–5.58) | 0.343 | |
B cells | − 8.059 | 0.00 (0.00–0.59) | 0.036 | * |
CD+ 8 cell | − 5.678 | 0.003 (0.00–0.50) | 0.026 | * |
CD4+ T cells | − 6.886 | 0.001 (0.00–1.69) | 0.069 | · |
Macrophages | 8.002 | 2987.33 (11.72–761,175.73) | 0.005 | ** |
Neutrphils | − 1.906 | 0.15 (0.00–14,422.16) | 0.745 | |
Dendritic | 5.098 | 163.78 (3.78–7097.75) | 0.008 | ** |
CENPM | 0.180 | 1.20 (1.04–1.38) | 0.012 | * |